Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size study, by Service Type (Contract Research Organizations, Contract Development and Manufacturing Organizations), by Indication (Oncology, Neurology, Cardiology, Infectious Diseases, Others

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size study, by Service Type (Contract Research Organizations, Contract Development and Manufacturing Organizations), by Indication (Oncology, Neurology, Cardiology, Infectious Diseases, Others), by Therapy (Cell Therapy, Gene Therapy, RNA-based Therapies, Others), by Phases (Preclinical Services, Clinical Services, Commercial Manufacturing and Packaging) and Regional Forecasts 2022-2032


The global advanced therapeutics pharmaceutical outsourcing market is valued approximately at USD 7,592.8 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.4% over the forecast period 2024-2032. Advanced therapeutics pharmaceutical outsourcing encompasses contracting specialized external partners to manage various stages of drug development and manufacturing for complex therapies. These advanced therapeutics include biologics, gene therapies, cell therapies, and personalized medicine. Outsourcing services range from research and development, clinical trials, regulatory compliance, to large-scale manufacturing. This approach allows pharmaceutical companies to leverage specialized expertise, state-of-the-art facilities, and innovative technologies without the significant capital investment required to develop these capabilities in-house. It also facilitates faster time-to-market, cost efficiencies, and the ability to focus on core competencies, ultimately enhancing patient access to cutting-edge treatments.

The rising complexity of advanced therapeutic modalities, such as gene editing, cell therapy, and mRNA-based drugs, demands specialized knowledge and sophisticated manufacturing capabilities. Pharmaceutical companies are increasingly partnering with outsourcing experts possessing advanced technical prowess to navigate the intricacies of these novel therapies. The burgeoning pipeline of advanced therapeutic products, driven by breakthroughs in biotechnology and genomics, has significantly amplified the demand for outsourcing services. As pharmaceutical companies concentrate on expanding their portfolios with innovative therapies, outsourcing emerges as a scalable and cost-effective solution for development and production.

The globalization of clinical trials for advanced therapeutics necessitates a network of partners with a global presence. Outsourcing facilitates access to diverse patient populations, regulatory environments, and manufacturing capabilities worldwide, supporting efficient and accelerated clinical development. A notable opportunity in the advanced therapeutics pharmaceutical outsourcing market lies in the expanding landscape of mRNA therapies. The increasing focus on mRNA therapies in cancer, infectious diseases, and genetic disorders presents a compelling opportunity for outsourcing partners. As pharmaceutical companies diversify their portfolios, outsourcing providers can offer specialized support in developing and manufacturing mRNA-based treatments. However, the advanced therapeutics pharmaceutical outsourcing market faces several challenges. One primary restrictive factor is the complex and evolving regulatory landscape governing advanced therapeutics. Regulatory agencies face challenges in establishing clear guidelines, as these therapies often involve cutting-edge technologies such as gene editing and cell therapy. This uncertainty can lead to delays in approvals and increase compliance burdens, impacting the speed at which outsourcing services can be leveraged.

The key regions considered for the global advanced therapeutics pharmaceutical outsourcing market study include North America, Europe, Asia Pacific, Latin America, and Rest of the World. North America is expected to dominate the market during the forecast period, driven by its robust economy, widespread adoption of advanced technologies, and significant presence of leading AI software and system suppliers. The region's strong research and development initiatives and substantial investments in the oil and gas industry further fuel the demand for advanced therapeutics pharmaceutical outsourcing.

Major market players included in this report are:

Croda International Plc

Charles River Laboratories International, Inc.

Catalent, Inc.

QuintilesIMS (IQVIA)

Parexel International Corporation

ICON plc

PPD, Inc. (Thermo Fisher Scientific)

LabCorp (Laboratory Corporation of America Holdings)

Syneos Health

WuXi AppTec

Lonza Group

Piramal Pharma Solutions

SGS SA

Evotec SE

CMC Biologics (Now AGC Biologics)

The detailed segments and sub-segment of the market are explained below:

By Service Type:
• Contract Research Organizations (CROs)
• Contract Development and Manufacturing Organizations (CDMOs)

By Indication:
• Oncology
• Neurology
• Cardiology
• Infectious Diseases
• Others

By Therapy:
• Cell Therapy
• Gene Therapy
• RNA-based Therapies
• Others

By Phases:
• Preclinical Services
• Clinical Services
• Commercial Manufacturing and Packaging

By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.


Chapter 1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Executive Summary
1.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Service Type
1.3.2. By Indication
1.3.3. By Therapy
1.3.4. By Phases
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Complexity of Advanced Therapeutic Modalities
3.1.2. Growing Pipeline of Advanced Therapeutic Products
3.1.3. Globalization of Clinical Trials
3.2. Market Challenges
3.2.1. Complex and Evolving Regulatory Landscape
3.2.2. High Cost of Advanced Therapeutics
3.3. Market Opportunities
3.3.1. Expanding Landscape of mRNA Therapies
3.3.2. Increasing Demand for Integrated Solutions
Chapter 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Service Type 2022-2032
5.1. Segment Dashboard
5.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Service Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Contract Research Organizations (CROs)
5.2.2. Contract Development and Manufacturing Organizations (CDMOs)
Chapter 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Cardiology
6.2.4. Infectious Diseases
6.2.5. Others
Chapter 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Therapy 2022-2032
7.1. Segment Dashboard
7.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Therapy Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Cell Therapy
7.2.2. Gene Therapy
7.2.3. RNA-based Therapies
7.2.4. Others
Chapter 8. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Phases 2022-2032
8.1. Segment Dashboard
8.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Phases Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Preclinical Services
8.2.2. Clinical Services
8.2.3. Commercial Manufacturing and Packaging
Chapter 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Region 2022-2032
9.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.1.1. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market
9.1.1.1. Service Type breakdown size & forecasts, 2022-2032
9.1.1.2. Indication breakdown size & forecasts, 2022-2032
9.1.1.3. Therapy breakdown size & forecasts, 2022-2032
9.1.1.4. Phases breakdown size & forecasts, 2022-2032
9.1.2. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.1. UK Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.2. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.3. France Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.4. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.5. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.6. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.2. India Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.3. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.4. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.5. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.6. Rest of Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.2. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.3. Rest of Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.1. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.2. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.3. Rest of Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Croda International Plc
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Charles River Laboratories International, Inc.
10.3.3. Catalent, Inc.
10.3.4. QuintilesIMS (IQVIA)
10.3.5. Parexel International Corporation
10.3.6. ICON plc
10.3.7. PPD, Inc. (Thermo Fisher Scientific)
10.3.8. LabCorp (Laboratory Corporation of America Holdings)
10.3.9. Syneos Health
10.3.10. WuXi AppTec
10.3.11. Lonza Group
10.3.12. Piramal Pharma Solutions
10.3.13. SGS SA
10.3.14. Evotec SE
10.3.15. CMC Biologics (Now AGC Biologics)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research AttributesList of Tables
TABLE 1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, report scope
TABLE 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by Region 2022-2032 (USD Million)
TABLE 3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by Service Type 2022-2032 (USD Million)
TABLE 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by Indication 2022-2032 (USD Million)
TABLE 5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by region, estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 16. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 18. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts, 2022-2032 (USD Million)
TABLE 19. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market estimates & forecasts by segment 2022-2032 (USD Million)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.List of Figures
FIGURE 1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, research methodology
FIGURE 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, market estimation techniques
FIGURE 3. Global market size estimates & forecast methods.
FIGURE 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, key trends 2023
FIGURE 5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, growth prospects 2022-2032
FIGURE 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, porters 5 force model
FIGURE 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, PESTEL analysis
FIGURE 8. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, value chain analysis
FIGURE 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, 2022 & 2032 (USD Million)
FIGURE 10. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, 2022 & 2032 (USD Million)
FIGURE 11. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, 2022 & 2032 (USD Million)
FIGURE 12. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, 2022 & 2032 (USD Million)
FIGURE 13. Global Advanced Therapeutics Pharmaceutical Outsourcing Market by segment, 2022 & 2032 (USD Million)
FIGURE 14. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, regional snapshot 2022 & 2032
FIGURE 15. North America Advanced Therapeutics Pharmaceutical Outsourcing Market 2022 & 2032 (USD Million)
FIGURE 16. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market 2022 & 2032 (USD Million)
FIGURE 17. Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market 2022 & 2032 (USD Million)
FIGURE 18. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market 2022 & 2032 (USD Million)
FIGURE 19. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market 2022 & 2032 (USD Million)
FIGURE 20. Global Advanced Therapeutics Pharmaceutical Outsourcing Market, company market share analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings